Sunshine Biopharma (SBFM) Interest Expenses (2012 - 2024)

Sunshine Biopharma has reported Interest Expenses for 12 years, with the latest figure at $8529.0 in Q4 2024.

• For the quarter ending Q4 2024, Interest Expenses fell 71.67% year-over-year to $8529.0; the trailing twelve-month figure through Sep 2025 stood at $8529.0 (down 89.28% YoY), and the FY2024 full-year result was $8774.0, down 93.61% from the prior year.
• Interest Expenses for Q4 2024 stood at $8529.0, up from $245.0 in the prior quarter.
• The five-year high for Interest Expenses was $195630.0 in Q2 2021, with the low at $2.0 in Q3 2022.
• Historically, Interest Expenses has averaged $39296.4 across 5 years, with a median of $28328.0 in 2022.
• Annual changes were most pronounced in 2022 — Interest Expenses tumbled 100.0% — and 2023, when it jumped 1926250.0%.
• Sunshine Biopharma's Interest Expenses stood at $105436.0 in 2020, then tumbled by 65.26% to $36630.0 in 2021, then retreated by 27.53% to $26546.0 in 2022, then grew by 13.43% to $30110.0 in 2023, then plunged by 71.67% to $8529.0 in 2024.
• The last three Interest Expenses figures came in at $8529.0 (Q4 2024), $245.0 (Q2 2024), and $49181.0 (Q1 2024), per Business Quant data.